The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of skeletal-related events on pain and analgesic use in patients with solid tumors and bone metastases.
Lesley Fallowfield
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Charles S. Cleeland
Consultant or Advisory Role - Amgen
Roger Von Moos
Consultant or Advisory Role - Amgen; Novartis; Roche
Honoraria - Amgen; Roche
Research Funding - Amgen; Roche
Expert Testimony - Roche (U); Sanofi (U)
Donald Patrick
Consultant or Advisory Role - Amgen
Jean-Jacques Body
Consultant or Advisory Role - Amgen
Honoraria - Amgen; Novartis
Research Funding - Amgen
Blair Egerdie
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Research Funding - Amgen
Alison Stopeck
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Janet Elizabeth Brown
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Novartis
Honoraria - Amgen; Novartis
Research Funding - Novartis
Gavin M. Marx
Honoraria - Amgen; AstraZeneca; Roche; Sanofi
Felipe Palazzo
No relevant relationships to disclose
Danail I Damyanov
No relevant relationships to disclose
Ying Zhou
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Ada Braun
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Arun Balakumaran
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Yi Qian
Employment or Leadership Position - Amgen
Stock Ownership - Amgen